• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同血统群体开发的2型糖尿病多基因风险评分的比较。

Comparison of polygenic risk scores for type 2 diabetes developed from different ancestry groups.

作者信息

Furukawa Takuma, Hara Megumi, Nishida Yuichiro, Tanaka Keitaro, Shimanoe Chisato, Iwasaka Chiharu, Otonari Jun, Ikezaki Hiroaki, Nagayoshi Mako, Tamura Takashi, Tamada Yudai, Okada Rieko, Oze Isao, Ito Hidemi, Michihata Nobuaki, Nakamura Yohko, Tanoue Shiroh, Koriyama Chihaya, Suzuki Sadao, Otani Takahiro, Watanabe Isao, Tomida Satomi, Kuriki Kiyonori, Takashima Naoyuki, Kadota Aya, Ishizu Masashi, Watanabe Takeshi, Nakatochi Masahiro, Momozawa Yukihide, Wakai Kenji, Matsuo Keitaro

机构信息

Department of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan.

Clinical Research Center, Saga University Hospital, Saga, Japan.

出版信息

NPJ Metab Health Dis. 2025 May 3;3(1):17. doi: 10.1038/s44324-025-00059-0.

DOI:10.1038/s44324-025-00059-0
PMID:40603767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12118717/
Abstract

Polygenic risk scores (PRS) are useful for assessing disease risk; however, knowledge about their effectiveness among Asian and other populations is limited. This study aimed to compare the classification accuracy of PRSs for type 2 diabetes (T2D-PRS) developed from different ancestry groups using genotype data from 14,083 Japanese participants. Participants' scores were calculated using T2D-PRS models, and logistic regression analysis and receiver operating characteristic curves were assessed. The odds ratio of diabetes per 1 standard deviation increase in PRS was 2.18 and 1.55 for the Japanese and European T2D-PRSs, respectively. The area under the curve (AUC) for the Japanese T2D-PRS was 0.781, whereas that for the European T2D-PRS was 0.738 (P < 0.001). Additionally, age-stratified analysis showed higher AUCs in younger than older age groups. The PRS developed from matched ancestry populations has high classification accuracy for diabetes and is particularly useful for the early detection of high-risk individuals with diabetes.

摘要

多基因风险评分(PRS)对于评估疾病风险很有用;然而,关于其在亚洲人群和其他人群中的有效性的知识有限。本研究旨在使用来自14,083名日本参与者的基因型数据,比较由不同祖先群体开发的2型糖尿病多基因风险评分(T2D-PRS)的分类准确性。使用T2D-PRS模型计算参与者的评分,并评估逻辑回归分析和受试者工作特征曲线。日本和欧洲T2D-PRS每增加1个标准差的糖尿病优势比分别为2.18和1.55。日本T2D-PRS的曲线下面积(AUC)为0.781,而欧洲T2D-PRS的曲线下面积为0.738(P < 0.001)。此外,年龄分层分析显示,年轻年龄组的AUC高于老年年龄组。从匹配的祖先群体开发的PRS对糖尿病具有较高的分类准确性,对于早期发现糖尿病高危个体特别有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed07/12118717/53bc2aee9b73/44324_2025_59_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed07/12118717/314c0cd87469/44324_2025_59_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed07/12118717/53bc2aee9b73/44324_2025_59_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed07/12118717/314c0cd87469/44324_2025_59_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed07/12118717/53bc2aee9b73/44324_2025_59_Fig2_HTML.jpg

相似文献

1
Comparison of polygenic risk scores for type 2 diabetes developed from different ancestry groups.不同血统群体开发的2型糖尿病多基因风险评分的比较。
NPJ Metab Health Dis. 2025 May 3;3(1):17. doi: 10.1038/s44324-025-00059-0.
2
Diagnostic Performance of Universal versus Stratified Computer-Aided Detection Thresholds for Chest X-Ray-Based Tuberculosis Screening.基于胸部X光的肺结核筛查中通用与分层计算机辅助检测阈值的诊断性能
medRxiv. 2025 Apr 10:2025.04.09.25325458. doi: 10.1101/2025.04.09.25325458.
3
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
All of Us diversity and scale improve polygenic prediction contextually with greatest improvements for under-represented populations.“我们所有人”项目的多样性和规模在情境中改善了多基因预测,对代表性不足的人群改善最大。
bioRxiv. 2024 Aug 6:2024.08.06.606846. doi: 10.1101/2024.08.06.606846.
10
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.替尔泊肽10毫克和15毫克与司美格鲁肽2.4毫克治疗2型糖尿病患者肥胖和超重的间接比较疗效与安全性
Diabetes Obes Metab. 2025 Jun 19. doi: 10.1111/dom.16508.

本文引用的文献

1
Body mass index stratification optimizes polygenic prediction of type 2 diabetes in cross-biobank analyses.体质指数分层优化了跨生物库分析中 2 型糖尿病的多基因预测。
Nat Genet. 2024 Jun;56(6):1100-1109. doi: 10.1038/s41588-024-01782-y. Epub 2024 Jun 11.
2
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology.2 型糖尿病病理生理学异质性的遗传驱动因素。
Nature. 2024 Mar;627(8003):347-357. doi: 10.1038/s41586-024-07019-6. Epub 2024 Feb 19.
3
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time.
糖尿病精准医学:潜力巨大,但陷阱和危险也不少,尚未准备好迎接黄金时代。
Diabetologia. 2022 Nov;65(11):1913-1921. doi: 10.1007/s00125-022-05782-7. Epub 2022 Aug 24.
4
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations.在不同人群中开发和验证 2 型糖尿病的跨种族多基因风险评分。
Genome Med. 2022 Jun 29;14(1):70. doi: 10.1186/s13073-022-01074-2.
5
Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.2型糖尿病的多血统基因研究凸显了不同人群在发现和转化研究方面的力量。
Nat Genet. 2022 May;54(5):560-572. doi: 10.1038/s41588-022-01058-3. Epub 2022 May 12.
6
Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores.利用精细映射和多人群训练数据提高跨人群多基因风险评分。
Nat Genet. 2022 Apr;54(4):450-458. doi: 10.1038/s41588-022-01036-9. Epub 2022 Apr 7.
7
Do gene-environment interactions have implications for the precision prevention of type 2 diabetes?基因-环境相互作用对 2 型糖尿病的精准预防有意义吗?
Diabetologia. 2022 Nov;65(11):1804-1813. doi: 10.1007/s00125-021-05639-5. Epub 2022 Jan 7.
8
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
9
Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.多基因风险评分与冠状动脉疾病:979286 名参与者数据的荟萃分析。
Atherosclerosis. 2021 Sep;333:48-55. doi: 10.1016/j.atherosclerosis.2021.08.020. Epub 2021 Aug 12.
10
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.多基因风险评分可预测糖尿病并发症及其对强化血压和血糖控制的反应。
Diabetologia. 2021 Sep;64(9):2012-2025. doi: 10.1007/s00125-021-05491-7. Epub 2021 Jul 6.